Advanced search

European Multicentric Study Group for Cabergoline in Lactation Inhibition: Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomized, double-blind, multicentre study. Brit. Med. J., 1991, 302, pp. 1367-1371.

Paul Defoort (UGent) and M THIERY
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Defoort, Paul, and M THIERY. “European Multicentric Study Group for Cabergoline in Lactation Inhibition: Single Dose Cabergoline Versus Bromocriptine in Inhibition of Puerperal Lactation: Randomized, Double-blind, Multicentre Study. Brit. Med. J., 1991, 302, Pp. 1367-1371.”
APA
Defoort, P., & THIERY, M. (n.d.). European Multicentric Study Group for Cabergoline in Lactation Inhibition: Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomized, double-blind, multicentre study. Brit. Med. J., 1991, 302, pp. 1367-1371.
Vancouver
1.
Defoort P, THIERY M. European Multicentric Study Group for Cabergoline in Lactation Inhibition: Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomized, double-blind, multicentre study. Brit. Med. J., 1991, 302, pp. 1367-1371.
MLA
Defoort, Paul, and M THIERY. “European Multicentric Study Group for Cabergoline in Lactation Inhibition: Single Dose Cabergoline Versus Bromocriptine in Inhibition of Puerperal Lactation: Randomized, Double-blind, Multicentre Study. Brit. Med. J., 1991, 302, Pp. 1367-1371.” n. pag. Print.
@article{224046,
  author       = {Defoort, Paul and THIERY, M},
  language     = {eng},
  title        = {European Multicentric Study Group for Cabergoline in Lactation Inhibition: Single dose cabergoline versus bromocriptine in inhibition of puerperal lactation: randomized, double-blind, multicentre study. Brit. Med. J., 1991, 302, pp. 1367-1371.},
}